Azelastine Hydrochloride is a trusted API for allergy relief that is widely used in intranasal therapies to manage allergic rhinitis effectively. Its rapid onset, non-sedative profile and proven performance makes it a preferred choice in regulated markets.

At Coral Drugs, we manufacture this API - Azelastine Hydrochloride, through full backward integration. That ensures end-to-end production control, regulatory compliance & consistent quality. This approach allows us to maintain a high assay, low impurity profile and deliver precision-engineered APIs optimized for intranasal formulations.

Our processes reflect strong commitment to purity, performance & meet all global standards. By minimizing variability and ensuring batch-to-batch consistency, we help our partners meet evolving regulatory expectations and respective market demands.

Coral Drug’s backward-integrated systems & processes don’t just improve quality, they build reliability. With science at our core, we align technical excellence with regulatory precision to deliver high quality APIs that support effective, safe and globally trusted therapies.

Whether you're expanding your allergy product line or enhancing existing formulations, Coral Drugs provides the support, control, and confidence needed in today’s pharmaceutical landscape.

Partner with us to access high-quality APIs that deliver on both performance and compliance.

‍

 Follow us on LinkedIn for the latest updates on our API portfolio and capabilities.

‍